HI

HIGH TECH PHARM CO.,LTD.

Develops and manufactures sterile, carbapenem-based antibiotic raw materials.

106190 | KO

Overview

Corporate Details

ISIN(s):
KR7106190002
LEI:
Country:
South Korea
Address:
충청북도 충주시 대소원면 첨단산업6로 12 (주)하이텍팜, 충주시

Description

HIGH TECH PHARM CO.,LTD. is a pharmaceutical company specializing in the development and manufacturing of active pharmaceutical ingredients (APIs), with a primary focus on sterile, carbapenem-based antibiotic raw materials. Established in 1998, the company has gained global recognition for its advanced technology and high-quality products, which are supplied to over 40 countries. A significant majority of its sales are generated from exports to demanding overseas markets, including Europe. The company operates state-of-the-art manufacturing facilities, such as its Chungju plant, designed to meet the rigorous standards of advanced regulatory authorities like the U.S. FDA and European EDQM. Through a commitment to a quality-first policy and continuous research and development, HIGH TECH PHARM aims to solidify its position as a leading global supplier of antibiotic drug substances.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2019-01-18 00:00
기타경영사항(자율공시)(충주공장 BGMP 실시상황 평가신청에 따른 식품의약품안전처 평가 적합판정)
Korean 6.4 KB
2019-01-08 00:00
[기재정정]분기보고서 (2017.03)
Korean 547.8 KB
2019-01-08 00:00
[기재정정]반기보고서 (2017.06)
Korean 529.0 KB
2019-01-08 00:00
[기재정정]분기보고서 (2017.09)
Korean 530.3 KB
2019-01-08 00:00
[기재정정]사업보고서 (2017.12)
Korean 657.9 KB
2019-01-08 00:00
[기재정정]분기보고서 (2018.03)
Korean 569.2 KB
2019-01-08 00:00
[기재정정]반기보고서 (2018.06)
Korean 549.1 KB
2019-01-08 00:00
[기재정정]분기보고서 (2018.09)
Korean 547.2 KB
2018-12-14 00:00
주주명부폐쇄기간또는기준일설정
Korean 4.4 KB
2018-12-07 00:00
주식등의대량보유상황보고서(일반)
Korean 77.0 KB
2018-12-05 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.2 KB
2018-11-14 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 22.2 KB
2018-11-14 00:00
주식등의대량보유상황보고서(일반)
Korean 79.5 KB
2018-11-14 00:00
분기보고서 (2018.09)
Korean 556.6 KB
2018-10-02 00:00
기업설명회(IR)개최
Korean 8.3 KB

Automate Your Workflow. Get a real-time feed of all HIGH TECH PHARM CO.,LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for HIGH TECH PHARM CO.,LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for HIGH TECH PHARM CO.,LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.